Literature DB >> 31786952

Development and evaluation of novel miltefosine-polyphenol co-loaded second generation nano-transfersomes for the topical treatment of cutaneous leishmaniasis.

M Junaid Dar1, Craig A McElroy2, Muhammad Ijaz Khan1,3, Abhay R Satoskar4, Gul Majid Khan1.   

Abstract

Objective: To test the hypothesis that miltefosine (MTF)-polyphenol co-loaded second-generation nano-transfersomes (SGNTs) can be an effective approach for the topical treatment of cutaneous leishmaniasis (CL).
Methods: The co-loaded SGNTs with various MTF-polyphenol combinations were developed, evaluated and compared for the entrapment efficiency, vesicle size, deformability index, ex-vivo permeation, cytotoxicity, and anti-leishmanial potential, using both in-vitro and in-vivo models.
Results: The co-loaded SGNTs were spherical in shape, with an average size of 119 ± 1.5 nm and a high entrapment efficiency of 73.7 ± 3.7%. The ex-vivo study displayed a 3.2-fold higher permeation of MTF when entrapped in co-loaded SGNTs, whereas cytotoxicity potential of co-loaded SGNTs was 43.2% higher than the MTF solution. A synergistic interaction was observed between MTF and apigenin (APG) among all polyphenols and an 8.0-fold lower IC50 was found against amastigotes of DsRed Leishmania mexicana, compared with the plain MTF solution. Moreover, the in-vivo studies displayed a 9.5-fold reduced parasitic burden in the L. mexicana infected BALB/c mice treated with MTF-APG co-loaded SGNTs gel.Conclusions: The potential of MTF-APG co-loaded SGNTs topical formulation is established for the first time as an effective drug delivery strategy against CL.

Entities:  

Keywords:  Miltefosine; apigenin; co-loaded second generation nano-transfersomes; cutaneous leishmaniasis; macrophage targeting; topical therapy

Mesh:

Substances:

Year:  2019        PMID: 31786952     DOI: 10.1080/17425247.2020.1700227

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  5 in total

Review 1.  Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight.

Authors:  Humzah Jamshaid; Fakhar Ud Din; Gul Majid Khan
Journal:  J Nanobiotechnology       Date:  2021-04-15       Impact factor: 10.435

Review 2.  Transfersomes: a Revolutionary Nanosystem for Efficient Transdermal Drug Delivery.

Authors:  Muhammad Waseem Akram; Humzah Jamshaid; Fiza Ur Rehman; Muhammad Zaeem; Jehan Zeb Khan; Ahmad Zeb
Journal:  AAPS PharmSciTech       Date:  2021-12-01       Impact factor: 3.246

3.  Antileishmanial Agents Co-loaded in Transfersomes with Enhanced Macrophage Uptake and Reduced Toxicity.

Authors:  Fatima Zahid; Sibgha Batool; Fakhar Ud-Din; Zakir Ali; Muhammad Nabi; Salman Khan; Omer Salman; Gul Majid Khan
Journal:  AAPS PharmSciTech       Date:  2022-08-16       Impact factor: 4.026

4.  Chloroform-Injection (CI) and Spontaneous-Phase-Transition (SPT) Are Novel Methods, Simplifying the Fabrication of Liposomes with Versatile Solution to Cholesterol Content and Size Distribution.

Authors:  Muhammad Ijaz Khan Khattak; Naveed Ahmed; Muhammad Farooq Umer; Amina Riaz; Nasir Mehmood Ahmad; Gul Majid Khan
Journal:  Pharmaceutics       Date:  2020-11-09       Impact factor: 6.321

5.  Macrophage targeting of nitazoxanide-loaded transethosomal gel in cutaneous leishmaniasis.

Authors:  Husna Khalid; Sibgha Batool; Fakhar Ud Din; Salman Khan; Gul Majid Khan
Journal:  R Soc Open Sci       Date:  2022-10-05       Impact factor: 3.653

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.